We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$928M
AUM Growth
-$26M
Cap. Flow
-$37.9M
Cap. Flow %
-4.08%
Top 10 Hldgs %
59.54%
Holding
150
New
27
Increased
25
Reduced
20
Closed
35
Avg Time Held
1.9 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.3 years

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$16.7M
2
RTX icon
RTX Corp
RTX
+$12.1M
3
GIS icon
General Mills
GIS
+$11M
4
GE icon
GE Aerospace
GE
+$9.69M
5
WFC icon
Wells Fargo
WFC
+$4.61M

Sector Composition

Rank Sector Weight
1 Financials 38.49%
2 Healthcare 20.5%
3 Industrials 9.59%
4 Miscellaneous 9.57%
5 Materials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CHL
51
DELISTED
China Mobile Limited
CHL
$2.19M 0.24%
48,300
– –
2018 Q1
5 quarters
RTX icon
52
RTX Corp
RTX
$252B
$1.95M 0.21%
23,756
-145,155
-86% -$12.1M
2014 Q1
21 quarters
JKHY icon
53
Jack Henry & Associates
JKHY
$11B
$1.83M 0.2%
13,700
– –
2017 Q2
8 quarters
VB icon
54
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
$1.81M 0.2%
11,560
+1,170
+11% +$181K
2019 Q1
1 quarter
KHC icon
55
The Kraft Heinz Company
KHC
$27.6B
$1.29M 0.14%
41,450
+19,900
+92% +$627K
2015 Q3
15 quarters
STOR
56
DELISTED
STORE Capital Corporation
STOR
$1.22M 0.13%
36,700
– –
2017 Q3
7 quarters
VHT icon
57
Vanguard Health Care ETF
VHT
$19.9B
$1.16M 0.13%
+6,690
New +$1.13M
2019 Q2
0 quarters
NDAQ icon
58
Nasdaq
NDAQ
$52.3B
$1.08M 0.12%
+33,600
New +$1.03M
2019 Q2
0 quarters
RVNC icon
59
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.04M 0.11%
+80,100
New +$1.01M
2019 Q2
0 quarters
ZTS icon
60
Zoetis
ZTS
$32.4B
$1.02M 0.11%
+9,000
New +$943K
2019 Q2
0 quarters
EOLS icon
61
Evolus
EOLS
$500M
$1M 0.11%
+68,500
New +$1.36M
2019 Q2
0 quarters
NOV icon
62
NOV
NOV
$6.64B
$976K 0.11%
43,900
– –
2014 Q1
21 quarters
DNOW icon
63
DNOW Inc
DNOW
$2.72B
$822K 0.09%
55,675
– –
2014 Q2
20 quarters
MDR
64
DELISTED
McDermott International
MDR
$730K 0.08%
75,600
– –
2018 Q2
4 quarters
BTI icon
65
British American Tobacco
BTI
$125B
$675K 0.07%
19,350
– –
2018 Q2
4 quarters
OMC icon
66
Omnicom Group
OMC
$22.1B
$661K 0.07%
8,070
+2,570
+47% +$203K
2017 Q4
6 quarters
AVXL icon
67
Anavex Life Sciences
AVXL
$137M
$587K 0.06%
174,080
– –
2018 Q4
2 quarters
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.13T
$576K 0.06%
2,700
+300
+13% +$62.1K
2018 Q3
3 quarters
ALPN icon
69
DELISTED
Alpine Immune Sciences Inc
ALPN
$511K 0.06%
121,363
-1,609
-1% -$9.29K
2018 Q4
2 quarters
ACAD icon
70
Acadia Pharmaceuticals
ACAD
$3.4B
$495K 0.05%
18,535
-1,465
-7% -$37.4K
2018 Q4
2 quarters
CRVS icon
71
Corvus Pharmaceuticals
CRVS
$829M
$486K 0.05%
130,000
– –
2018 Q3
3 quarters
IFF icon
72
International Flavors & Fragrances
IFF
$23B
$474K 0.05%
+3,270
New +$454K
2019 Q2
0 quarters
TGTX icon
73
TG Therapeutics
TGTX
$8.57B
$433K 0.05%
50,000
– –
2017 Q1
9 quarters
EWY icon
74
iShares MSCI South Korea ETF
EWY
$22.3B
$422K 0.05%
7,050
– –
2019 Q1
1 quarter
DVAX icon
75
DELISTED
Dynavax Technologies
DVAX
$421K 0.05%
105,573
– –
2017 Q1
9 quarters

Similar funds

Hikari Power's Q2 2019 Portfolio in Review

As of Q2 2019, Hikari Power held 150 positions worth $928M, down 2.7% from $954M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power withdrew a net $37.9M in Q2 2019, closing 35 positions and reducing 20 holdings. Its most notable exit was Sanofi, an estimated $3.15M position sold in full.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Hikari Power opened a new position in Vanguard Short-Term Bond ETF worth $9.23M.

  • Hikari Power's largest Q2 2019 buy was Vanguard Short-Term Bond ETF: 114,600 shares worth $9.23M.
  • Hikari Power added most to Altria Group in Q2 2019, an estimated $5.27M increase.
  • Hikari Power's biggest Q2 2019 reduction was IBM, cutting an estimated $16.7M.
  • Hikari Power fully exited Sanofi in Q2 2019, selling an estimated $3.15M.
  • Hikari Power's ten largest holdings make up 60% of its $928M portfolio in Q2 2019.
  • Hikari Power opened 27 new positions and closed 35 in Q2 2019.
  • Hikari Power's portfolio value fell 2.7% quarter-over-quarter to $928M.

Based on Hikari Power's 13F filing for Q2 2019, filed 8 Aug 2019.